4.1 Article

Cost-effectiveness of dabigatran etexilate in the prevention of stroke and systemic embolism in patients with atrial fibrillation in Belgium

Journal

JOURNAL OF MEDICAL ECONOMICS
Volume 16, Issue 3, Pages 407-414

Publisher

Informa Healthcare
DOI: 10.3111/13696998.2013.766200

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available